Belmondo is a venture capital fund focused on health tech companies at the Series B stage, with investments ranging from $250,000 to $5 million. They aim to help businesses grow and succeed in the health technology sector. Notable investment includes Hemotune. Belmondo is dedicated to advancing health tech by providing financial support and guidance to promising entrepreneurs.
